RGEN
Repligen Corporation
NASDAQ: RGEN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$165.18
+0.30% today
Updated 2026-09-11
Market cap
$9.51B
P/E ratio
227.74
P/S ratio
12.11x
EPS (TTM)
$0.74
Dividend yield
—
52W range
$101 – $189
Volume
1.1M
Repligen Corporation (RGEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$165.18
12-Month target
$40.25
2030 Target
—
Intrinsic (DCF)
$159.07
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.7B | $0.8B | $0.6B | $0.6B | $0.7B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 5.29%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.